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= Abstract = DNA amplification and HhaI cleavage for the apolipoprotein E (apofi)
genotyping is identified in 108 patients with coronary artery disease (CAD). A group
of randomly selected 100 normal individuals analysed as control samples. There
were no significant differences in apoE genotype frequencies between the two groups.
Analysis of variances was performed to test for mean differences in plasma lipids.
lipoprotein and apolipoprotein B (apoB) levels. Compared to controls, patients with
CAD had significantly higher levels of total cholesterol (TC) and low density
lipoprotein-cholesterol (LDL-ChoI). The ratios of LDL-Chol to apoB were also
elevated in the CAD group. The levels of TC and LDL-Chol in the E3j3 genotype of
patients were significantly higher than those of the controls. The high density
Iipoprotein-cholesteroI(HDL-ChoI) levels in E4 j3 type of the patients were
significantly higher than those of E3j3 subjects. As phenotype analysis for the apoE
polymorphism differs somewhat among populations, so we discussed possible
reasons for these discrepancies.
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INTRODUCTION
Apolipoprotein E(apoE) is one of the most
extensively studied of all the apolipoproteins. It is
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a structural and functional constituent of
chylomicrons, very low density lipoprotein (VLDL),
and some subfractions of HDL. Apo E serves as a
ligand for LDL (apo B,E) and apo E receptors.
And it allows a specific uptake of its carrier
lipoprotein particles by the hepatic cells (Mahley
et a/. 1984; Brown and Goldstein. 1986; Beisiegel
et a/. 1988). In addition, apoE is also involved in
the conversion of VLDL to LDL (Enholm et al.
1984). Thus apoE plays an important role in
lipoprotein metabolism and may be involved in
atherogenesis.
Three major apoE isoproteins, apoE2, E3, and








